Literature DB >> 16834872

Polypharmacy, appropriate and inappropriate.

Jeffrey K Aronson.   

Abstract

Mesh：

Year:  2006        PMID： 16834872      PMCID： PMC1872056     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  5 in total

1.  In defence of polypharmacy.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2004-02       Impact factor: 4.335

2.  Rational prescribing, appropriate prescribing.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2004-03       Impact factor: 4.335

3.  Analysis of polypharmacy in older patients in primary care using a multidisciplinary expert panel.

Authors:  Wilma Denneboom; Maaike G H Dautzenberg; Richard Grol; Peter A G M De Smet
Journal:  Br J Gen Pract       Date:  2006-07       Impact factor: 5.386

4.  A strategy to reduce cardiovascular disease by more than 80%.

Authors:  N J Wald; M R Law
Journal:  BMJ       Date:  2003-06-28

Review 5.  The role of oral antidiabetic agents: why and when to use an early-phase insulin secretion agent in Type II diabetes mellitus.

Authors:  E Standl; M Füchtenbusch
Journal:  Diabetologia       Date:  2002-12-18       Impact factor: 10.122
  5 in total
  10 in total

1.  Adverse drug reactions--no farewell to harms.

Authors:  Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2007-02       Impact factor: 4.335

2.  Balanced prescribing.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2006-12       Impact factor: 4.335

Review 3.  Medication review in hospitalised patients to reduce morbidity and mortality.

Authors:  Mikkel Christensen; Andreas Lundh
Journal:  Cochrane Database Syst Rev       Date:  2016-02-20

Review 4.  Interventions to improve the appropriate use of polypharmacy for older people.

Authors:  Audrey Rankin; Cathal A Cadogan; Susan M Patterson; Ngaire Kerse; Chris R Cardwell; Marie C Bradley; Cristin Ryan; Carmel Hughes
Journal:  Cochrane Database Syst Rev       Date:  2018-09-03

5.  The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010.

Authors:  Bruce Guthrie; Boikanyo Makubate; Virginia Hernandez-Santiago; Tobias Dreischulte
Journal:  BMC Med       Date:  2015-04-07       Impact factor: 8.775

6.  The challenge to define a relevant change in medication appropriateness index score in older adults - An approach.

Authors:  Laura Krisch; Angelika Mahlknecht; Ulrike Bauer; Nadja Nestler; Georg Hempel; Jürgen Osterbrink; Maria Flamm
Journal:  Br J Clin Pharmacol       Date:  2020-01-12       Impact factor: 4.335

7.  Impact of training and structured medication review on medication appropriateness and patient-related outcomes in nursing homes: results from the interventional study InTherAKT.

Authors:  Angelika Mahlknecht; Laura Krisch; Nadja Nestler; Ulrike Bauer; Nina Letz; Daniel Zenz; Jochen Schuler; Laura Fährmann; Georg Hempel; Maria Flamm; Jürgen Osterbrink
Journal:  BMC Geriatr       Date:  2019-09-18       Impact factor: 3.921

8.  Dispensed drugs and multiple medications in the Swedish population: an individual-based register study.

Authors:  Bo Hovstadius; Bengt Astrand; Göran Petersson
Journal:  BMC Clin Pharmacol       Date:  2009-05-27

9.  Residential Medication Management Reviews and continuous polypharmacy among older Australian women.

Authors:  Kaeshaelya Thiruchelvam; Julie Byles; Syed Shahzad Hasan; Nicholas Egan; Therese Kairuz
Journal:  Int J Clin Pharm       Date:  2021-06-06

10.  Identifying enablers and barriers to individually tailored prescribing: a survey of healthcare professionals in the UK.

Authors:  Joanne Reeve; Nicky Britten; Richard Byng; Jo Fleming; Janet Heaton; Janet Krska
Journal:  BMC Fam Pract       Date:  2018-01-15       Impact factor: 2.497
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.